c-ets-2 protooncogene has mitogenic and oncogenic activity.
about
EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genesHepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cellsERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulationReciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cellp300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoterCloning and characterization of GETS-1, a goldfish Ets family member that functions as a transcriptional repressor in muscle.Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.Ets transcription factors and targets in osteogenesis.Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.Regulators of gene expression as biomarkers for prostate cancerThe Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques.DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcomav-myb and v-ets cooperate for the mitogenic stimulation of primary fibroblasts by avian E26 retrovirusThe role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapyMolecular and functional characterization of the promoter of ETS2, the human c-ets-2 geneThe transcription factor ETS1 in lymphomas: friend or foe?Localization of the c-ets-2 transactivation domainETS transcription factors and targets in tumour invasion, angiogenesis and bone metastasis.Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer.Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.ETV1 positively regulates transcription of tumor suppressor ARF.Eureka! Ets a target for fibrosis!Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.Transcriptional activity and constitutive nuclear localization of the ETS protein Elf-1.Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.Apoptosis in Down's syndrome: lessons from studies of human and mouse models.The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.Identification of a second promoter in the human c-ets-2 proto-oncogene
P2860
Q22253257-22640EAB-C3D8-408D-8ACD-C5A72B26091FQ22254707-AFD3645A-34A9-420D-8386-45219E673C6BQ24313680-D28ABAFF-3997-48F4-8C05-5B7D31196D36Q24336327-AA30C6F8-9CC3-4F35-988B-BF0AC99D3AE5Q24629399-A20C8771-972A-43FB-9C2D-60FBBF9B5BC8Q28259950-34DEDFD7-FCC8-47DD-AC84-D8B2852B557FQ28610029-C5177C0A-89E4-44FA-9650-7F42C36ADB08Q32005878-1048EFFC-A5A4-4EE3-8DDA-5268DB953975Q33943441-6DFD71F4-E5C4-4AC2-BA13-02723FC2D405Q34139388-45995FDB-D0B0-4EC5-B3AC-F1E6CC7F6CEFQ34289899-18E31F03-7DB6-4DBF-8850-51B86042D8B4Q36439912-901CE438-1BAE-4A59-9F3D-B1098861D8F1Q36479295-7CFA1A7C-F3C3-4AE8-B536-00748884BCE4Q36650465-AA7FB00A-1EEF-4534-AD7D-78638F2F1A1BQ36652613-BBE92788-F116-4312-8FDD-7E89FD074230Q36701869-6161E9B9-A6E3-466A-B1F8-C213A157AB93Q37259709-21A7FD0F-371C-4EAA-A2E1-D9FFF5598A2BQ37685279-3E1E36C5-F415-4965-814C-784BF1233134Q38264349-153D5021-FCE1-4F15-B308-432C3D61D1B5Q38320480-F195265C-E307-4B17-AB00-C345A00AB987Q38324197-1CD039BF-F73A-4956-906E-0AA3CDF25988Q38337648-CAFD824A-AB03-408C-A27F-68B2466C98A7Q38348367-50DEA26A-7792-464C-96BE-D730EF01547FQ38358127-9B201608-0AAF-451E-ADD4-AB88ECB0C7C7Q39071032-AC677634-7489-4B3D-9A6F-2B8A4107347AQ39986867-4C0D954F-3C73-4E14-9EAB-F68C56CD5037Q40665255-F2556D1E-9455-4A0B-BBB3-ADBEFB316730Q41080680-1F49A831-BCF4-4E04-8BEF-5D2DECEA4C16Q41110548-678F8A7B-08C0-446A-B79E-2D90B4B42465Q42828149-5653DD9C-5FAE-45A3-B5F9-AABF214A4384Q43723779-79EADEEE-E079-4E15-A3D0-284B51B95A15Q52538890-BE3455A2-A448-4E03-872E-0E457BBFB554Q58707970-85B01132-35FC-47CA-9BF9-4101042DC737
P2860
c-ets-2 protooncogene has mitogenic and oncogenic activity.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@ast
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@en
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@nl
type
label
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@ast
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@en
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@nl
prefLabel
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@ast
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@en
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@nl
P2093
P2860
P356
P1476
c-ets-2 protooncogene has mitogenic and oncogenic activity.
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.20.7833
P407
P577
1989-10-01T00:00:00Z